- CYBX's revenue growth has slightly outpaced the industry average of 8.6%. Since the same quarter one year prior, revenues slightly increased by 9.5%. Growth in the company's revenue appears to have helped boost the earnings per share.
- CYBX has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 5.99, which clearly demonstrates the ability to cover short-term cash needs.
- The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, CYBERONICS INC's return on equity exceeds that of both the industry average and the S&P 500.
- CYBERONICS INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, CYBERONICS INC increased its bottom line by earning $2.00 versus $1.65 in the prior year. This year, the market expects an improvement in earnings ($2.36 versus $2.00).
- The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 59.8% when compared to the same quarter one year prior, rising from $11.53 million to $18.43 million.
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. The Health Services industry as a whole was unchanged today versus the S&P 500, which was up 0.3%. Laggards within the Health Services industry included American Shared Hospital Services ( AMS), down 1.6%, Electromed ( ELMD), down 9.1%, Semler Scientific ( SMLR), down 1.7%, Daxor ( DXR), down 2.5% and Dynatronics ( DYNT), down 3.5%. TheStreet Ratings Group would like to highlight 3 stocks that pushed the industry lower today: Cyberonics ( CYBX) is one of the companies that pushed the Health Services industry lower today. Cyberonics was down $3.79 (6.1%) to $58.27 on heavy volume. Throughout the day, 1,085,779 shares of Cyberonics exchanged hands as compared to its average daily volume of 237,400 shares. The stock ranged in price between $56.52-$59.92 after having opened the day at $59.92 as compared to the previous trading day's close of $62.06. Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells implantable medical devices to hospitals and ambulatory surgery centers. Cyberonics has a market cap of $1.7 billion and is part of the health care sector. Shares are down 4.3% year-to-date as of the close of trading on Wednesday. Currently there are 7 analysts who rate Cyberonics a buy, no analysts rate it a sell, and 1 rates it a hold. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreet Ratings rates Cyberonics as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Highlights from TheStreet Ratings analysis on CYBX go as follows: